OSLO, Norway, March 31, 2023 /PRNewswire/ -- The Board of Directors of Nordic Nanovector ASA has decided to postpone the upcoming Annual General Meeting (AGM), which was originally scheduled for 2...
Nordic Nanovector is a Norway-based biopharmaceutical company that researches and develops radioimmunotherapies for the treatment of hematological cancers.